Cargando…

Bone morphogenetic proteins and the polycystic ovary syndrome

BACKGROUND: Polycystic Ovary Syndrome (PCOS) is defined by two out of the following three criteria being met: oligo- or anovulation, hyperandrogenism, and polycystic ovaries. Affected women are often obese and insulin resistant. Although the etiology is still unknown, members of the Transforming Gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Houten, E Leonie AF, Laven, Joop SE, Louwers, Yvonne V, McLuskey, Anke, Themmen, Axel PN, Visser, Jenny A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642026/ https://www.ncbi.nlm.nih.gov/pubmed/23627969 http://dx.doi.org/10.1186/1757-2215-6-32

Ejemplares similares

Characteristics of polycystic ovary syndrome throughout life
por: Louwers, Yvonne V., et al.
Publicado: (2020)

Estrogens increase expression of bone morphogenetic protein 8b in brown adipose tissue of mice
por: Grefhorst, Aldo, et al.
Publicado: (2015)

OR35-04 Anti-Müllerian Hormone Variants identified in Patients with Polycystic Ovary Syndrome Affect Secretion and Immunoactivity
por: Meng, Li, et al.
Publicado: (2023)

Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome
por: Moolhuijsen, Loes M E, et al.
Publicado: (2022)

Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients
por: Moolhuijsen, Loes M E, et al.
Publicado: (2022)

SUN-008 Loss of Antimullerian Hormone Immunoreactivity Due to a Homozygous AMH Gene Mutation Rs10417628 in a Woman with Classical Polycystic Ovary Syndrome
por: Hoyos, Luis R, et al.
Publicado: (2020)

Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity?
por: Huijgen, Nicole A., et al.
Publicado: (2015)

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
por: Meun, Cindy, et al.
Publicado: (2019)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
por: Laven, Joop S. E.
Publicado: (2019)

SUN-108 Dose-Dependent Effect of Progesterone on T37i Brown Adipocyte Differentiation
por: Kaikaew, Kasiphak, et al.
Publicado: (2019)

MON-208 Association Study of AMH Promoter Polymorphisms and Serum AMH Levels in PCOS Patients
por: Moolhuijsen, Loes, et al.
Publicado: (2019)

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS
por: Jiskoot, Geranne, et al.
Publicado: (2023)

BMI-Associated Alleles Do Not Constitute Risk Alleles for Polycystic Ovary Syndrome Independently of BMI: A Case-Control Study
por: Louwers, Yvonne V., et al.
Publicado: (2014)

Loss of Anti-Müllerian Hormone Signaling in Mice Affects Trabecular Bone Mass in a Sex- and Age-Dependent Manner
por: van As, Christiane, et al.
Publicado: (2022)

Sexual Function in Women With Polycystic Ovary Syndrome: Design of an Observational Prospective Multicenter Case Control Study
por: Pastoor, Hester, et al.
Publicado: (2020)

Lifestyle treatment in women with polycystic ovary syndrome: predictors of weight loss and dropout
por: Jiskoot, Geranne, et al.
Publicado: (2022)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies
por: Hiam, Danielle, et al.
Publicado: (2019)

Functional analysis of rare anti-Müllerian hormone protein-altering variants identified in women with PCOS
por: Meng, L, et al.
Publicado: (2023)

Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study
por: Krul-Poel, Y. H. M., et al.
Publicado: (2018)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome(†)(‡)
por: Teede, Helena J, et al.
Publicado: (2018)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J., et al.
Publicado: (2018)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J., et al.
Publicado: (2018)

Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence
por: Steegers-Theunissen, Régine P. M., et al.
Publicado: (2020)

Changes in eating behavior through lifestyle treatment in women with polycystic ovary syndrome (PCOS): a randomized controlled trial
por: Jiskoot, Geranne, et al.
Publicado: (2022)

Comparative structural analysis of the caspase family with other clan CD cysteine peptidases
por: McLuskey, Karen, et al.
Publicado: (2015)

Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome
por: Day, Felix R., et al.
Publicado: (2015)

Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J, et al.
Publicado: (2019)

THU629 Cluster Analysis Identifies Distinct Subtypes Of PCOS
por: van der Ham, Kim, et al.
Publicado: (2023)

Pregnancy Outcomes in Women with PCOS: Follow-Up Study of a Randomized Controlled Three-Component Lifestyle Intervention
por: Dietz de Loos, Alexandra, et al.
Publicado: (2023)

Polycystic ovarian morphology in Thai women of reproductive age with polycystic ovary syndrome
por: Wongwananuruk, Thanyarat, et al.
Publicado: (2020)

Polycystic Ovary Syndrome and COVID-19: An Emerging Risk Factor
por: Joshi, Shashank R.
Publicado: (2021)

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome
por: Fraser, Graeme L, et al.
Publicado: (2021)

Shared Genetics Between Age at Menopause, Early Menopause, POI and Other Traits
por: Louwers, Yvonne V., et al.
Publicado: (2021)

Bone morphogenetic protein 2 promotes primordial follicle formation in the ovary
por: Chakraborty, Prabuddha, et al.
Publicado: (2015)

The relationship between quality of life and coping strategies in polycystic ovary syndrome patients
por: Kolahi, Leila, et al.
Publicado: (2015)

Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome
por: Caanen, Mirte R, et al.
Publicado: (2020)

Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial
por: Jiskoot, Geranne, et al.
Publicado: (2020)

Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
por: Teede, Helena J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_btf0ah3mon3qour0h8ldcbvhqu